Preemptive Therapy of EBV-Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation (Q57275302)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

30 December 2019

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Marco Zecca

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Fausto Baldanti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Marco Paulli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Comoli P

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Pagliara D

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Bernardo ME

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Barberi W

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Moretta A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Labirio M

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Furione M

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Maccario R

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Locatelli F

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Transplantation

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

1648-1655

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

Immunotherapy for post-transplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

Treatment of EBV-Related Post-Renal Transplant Lymphoproliferative Disease with a Tailored Regimen Including EBV-Specific T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01823.X

10.1111/J.1600-6143.2007.01823.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17511690%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference